Interactions with RNA direct the Polycomb group protein SCML2 to chromatin where it represses target genes
Roberto Bonasio,
Emilio Lecona,
Varun Narendra,
Philipp Voigt,
Fabio Parisi,
Yuval Kluger,
Danny Reinberg
Affiliations
Roberto Bonasio
Department of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University School of Medicine, New York, United States
Emilio Lecona
Department of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University School of Medicine, New York, United States
Varun Narendra
Department of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University School of Medicine, New York, United States
Philipp Voigt
Department of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University School of Medicine, New York, United States
Fabio Parisi
Department of Pathology, Yale University School of Medicine, New Haven, United States; Yale Cancer Center, Yale University School of Medicine, New Haven, United States
Yuval Kluger
Department of Pathology, Yale University School of Medicine, New Haven, United States; Yale Cancer Center, Yale University School of Medicine, New Haven, United States
Danny Reinberg
Department of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University School of Medicine, New York, United States
Polycomb repressive complex-1 (PRC1) is essential for the epigenetic regulation of gene expression. SCML2 is a mammalian homolog of Drosophila SCM, a Polycomb-group protein that associates with PRC1. In this study, we show that SCML2A, an SCML2 isoform tightly associated to chromatin, contributes to PRC1 localization and also directly enforces repression of certain Polycomb target genes. SCML2A binds to PRC1 via its SPM domain and interacts with ncRNAs through a novel RNA-binding region (RBR). Targeting of SCML2A to chromatin involves the coordinated action of the MBT domains, RNA binding, and interaction with PRC1 through the SPM domain. Deletion of the RBR reduces the occupancy of SCML2A at target genes and overexpression of a mutant SCML2A lacking the RBR causes defects in PRC1 recruitment. These observations point to a role for ncRNAs in regulating SCML2 function and suggest that SCML2 participates in the epigenetic control of transcription directly and in cooperation with PRC1.